SBHIX Holdings — Saratoga Health & Biotechnology Portfolio
All 29 reported holdings of Saratoga Health & Biotechnology Portfolio (SBHIX) by percentage of net assets, from the fund's latest SEC N-PORT filing.
| Holding | % of net assets | Value (USD) |
|---|---|---|
| Cardinal Health, Inc. | 6.44% | $674.83K |
| Jazz Pharmaceuticals PLC | 6.19% | $648.22K |
| United Therapeutics Corp. | 6.17% | $645.91K |
| Amgen, Inc. | 5.04% | $527.75K |
| Mckesson Corp. | 4.90% | $513.03K |
| Lantheus Holdings, Inc. | 4.64% | $486.57K |
| Exelixis, Inc. | 4.55% | $476.78K |
| Novartis AG | 4.50% | $471.53K |
| Cencora, Inc. | 4.33% | $453.33K |
| Gilead Sciences, Inc. | 3.94% | $412.43K |
| Regeneron Pharmaceuticals, Inc. | 3.93% | $411.90K |
| Johnson & Johnson | 3.91% | $410.10K |
| National Healthcare Corp. | 3.72% | $389.50K |
| Merck & Company, Inc. | 3.63% | $380.62K |
| Cigna Group (the) | 3.63% | $380.32K |
| Medpace Holdings, Inc. | 3.37% | $353.22K |
| Vertex Pharmaceuticals, Inc. | 3.36% | $352.21K |
| Intuitive Surgical, Inc. | 3.14% | $329.10K |
| Bristol-Myers Squibb Company | 3.07% | $321.92K |
| Incyte Corp. | 2.89% | $302.99K |
| Stryker Corp. | 2.40% | $251.70K |
| Medtronic PLC | 2.20% | $230.73K |
| Eli Lilly & Company | 2.11% | $221.00K |
| Labcorp Holdings, Inc. | 2.11% | $220.79K |
| Elevance Health, Inc. | 1.63% | $170.25K |
| Ensign Group, Inc. (the) | 1.60% | $167.48K |
| Dreyfus Institutional Preferred Money Market Funds | 1.56% | $162.98K |
| Novo Nordisk A/s | 1.55% | $162.26K |
| Dreyfus Treasury Obligations Cash Management | 0.00% | $0 |
SBHIX overview: performance, fees, allocation and SEC filings